Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 15, 2023 - Issue
Submit an article Journal homepage
274
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Work Loss and Direct and Indirect Costs Associated with Parkinson’s Disease

Michelle Jerry1 Merative, Ann Arbor, MI, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1664-8090View further author information
ORCID Icon,
Steve Arcona2 Cerevel Therapeutics, Cambridge, MA, USAORCID Iconhttps://orcid.org/0000-0001-7926-5420View further author information
ORCID Icon,
Donna McMorrow1 Merative, Ann Arbor, MI, USAView further author information
,
Hana Schwartz1 Merative, Ann Arbor, MI, USAView further author information
,
Nicole Princic1 Merative, Ann Arbor, MI, USAView further author information
&
Rahul Sasane2 Cerevel Therapeutics, Cambridge, MA, USAView further author information
Pages 309-319 | Received 08 Dec 2022, Accepted 15 Apr 2023, Published online: 27 Apr 2023

References

  • Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013. doi:10.1038/nrdp.2017.13
  • Marras C, Beck JC, Bower JH, et al. Prevalence of Parkinson’s disease across North America. NPJ Parkinsons Dis. 2018;4:21. doi:10.1038/s41531-018-0058-0
  • Huse DM, Schulman K, Orsini L, et al. Burden of illness in Parkinson’s disease. Mov Disord. 2005;20:1449–1454. doi:10.1002/mds.20609
  • Martinez-Martin P, Macaulay D, Jalundhwala YJ, et al. The long-term direct and indirect economic burden among Parkinson’s disease caregivers in the United States. Mov Disord. 2019;34:236–245. doi:10.1002/mds.27579
  • Yang G, Schmiel L, Zhou M, et al. Economic Burden and Future Impact of Parkinson’s Disease. Falls Church, VA, USA: The Lewin Group, Inc; 2019.
  • Whetten-Goldstein K, Sloan F, Kulas E, et al. The burden of Parkinson’s disease on society, family, and the individual. J Am Geriatr Soc. 1997;45:844–849. doi:10.1111/j.1532-5415.1997.tb01512.x
  • Yang W, Hamilton JL, Kopil C, et al. Current and projected future economic burden of Parkinson’s disease in the U.S. NPJ Parkinsons Dis. 2020;6:15. doi:10.1038/s41531-020-0117-1
  • Kowal SL, Dall TM, Chakrabarti R, et al. The current and projected economic burden of Parkinson’s disease in the United States. Mov Disord. 2013;28:311–318. doi:10.1002/mds.25292
  • U.S Bureau of Labor Statistics. Labor force statistics from the current population survey. Available from: https://www.bls.gov/cps/aa2019/cpsaat37.htm. Accessed November 7, 2022.
  • Sveinbjornsdottir S. The clinical symptoms of Parkinson’s disease. J Neurochem. 2016;139(Suppl 1):318–324. doi:10.1111/jnc.13691
  • Wood BH, Bilclough JA, Bowron A, et al. Incidence and prediction of falls in Parkinson’s disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry. 2002;72:721–725. doi:10.1136/jnnp.72.6.721
  • Pringsheim T, Day GS, Smith DB, et al. Dopaminergic therapy for motor symptoms in early Parkinson disease practice guideline summary: a report of the AAN guideline subcommittee. Neurology. 2021;97(20):942–957.
  • Marsili L, Bologna M, Miyasaki JM, Colosimo C. Parkinson’s disease advanced therapies - A systematic review: more unanswered questions than guidance. Parkinsonism Relat Disord. 2021;83:132–139. doi:10.1016/j.parkreldis.2020.10.042

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.